Category Archives: Trends

Section 1332 Opportunity for Pharmaceutical Manufacturers

Section 1332 Opportunity for Pharmaceutical Manufacturers – by Gregory Judd, CEBS   A funny thing happened while pharmaceutical manufacturers were going through wrenching strategic and organizational changes during the past 6 or 7 years. The Affordable Care Act. Ok, so ACA is not all THAT funny. But it IS big, and has exerted a sort of […]

Pharmaceutical Growth Driven by M&A and Shareholder Value

Pharmaceutical Growth Driven by M&A and Shareholder Value – Biologic and Pharmaceutical companies, along with their financial advisors or venture capital partners, have used mergers and acquisitions over the years to create value in order to keep their leading positions in a changing market. The era of pharmaceutical companies relying on blockbusters for their growth […]

Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace

By John Santilli, MBA, and F. Randy Vogenberg, PhD, RPh After the passage of the Affordable Care Act (ACA) in 2010, market changes beyond those already in play began to emerge. Traditional roles, responsibilities, and authority could now be tested or altered as a result of some sections of the ACA. One result is that […]

Trends: Big Brands Reducing Negative Impact

Consumers are paying attention.  From Goodwill’s obnoxiously low pay for disabled workers to the latest smoke-and-mirrors shuffling from quantitative easing, consumers are watching brands and businesses far more closely than in recent years for unethical policies and practices. In response, businesses are becoming much more proactive in reducing negative impacts to their brand, because they […]